Literature DB >> 1888247

Iatrogenic renal disease.

M Davidman1, P Olson, J Kohen, T Leither, C Kjellstrand.   

Abstract

We studied iatrogenic problems in nephrology by classifying all patients for nephrology consultation into nine presenting syndromes and seven etiologic groups. One hundred (2.2%) of all admissions were seen in nephrology consultation. Acute renal failure was the most common presenting syndrome, accounting for 59% of the consultations. Forty-one of the 100 consultations (1% of all admissions) had a renewal syndrome of iatrogenic origin. Of these 41 patients, 38 had acute renal failure and three had fluid and electrolyte problems. Twenty of the 41 patients had drug-induced problems. Eighteen of these patients were dehydrated, and in three patients, acute renal failure occurred after surgery. Of the 20 patients with iatrogenic renal problems caused by drugs, seven problems were antibiotic related, five were due to diuretics, four were due to nonsteroidal anti-inflammatory drugs, three were due to angiotensin-converting enzyme inhibitors, and one was from the use of contrast medium. The 41 patients with iatrogenic-related renal disease were older than the other 59 patients (61.8 vs 49.3 years). Iatrogenic renal disease developed in 1% of all patients admitted to a tertiary care hospital, and 12% of these patients died. The most common renal syndrome is acute renal failure, most often caused by nephrotoxic drugs. The incidence can probably be decreased by better monitoring of body weight and fluid balance to prevent dehydration and by the avoidance of nephrotoxic drugs.

Entities:  

Mesh:

Year:  1991        PMID: 1888247

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

Review 1.  Renal failure after eating "magic" mushrooms.

Authors:  E Raff; P F Halloran; C M Kjellstrand
Journal:  CMAJ       Date:  1992-11-01       Impact factor: 8.262

Review 2.  Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity.

Authors:  Melissa Martin; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

Review 3.  Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment.

Authors:  W Ailabouni; G Eknoyan
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

4.  Clinical cause of presumed acute tubular necrosis requiring renal replacement therapy and outcome of critically ill patients: post hoc analysis of a prospective 7-year cohort study.

Authors:  H Schiffl; R Fischer
Journal:  Int Urol Nephrol       Date:  2011-05-28       Impact factor: 2.370

5.  A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report.

Authors:  Allison B McCoy; Lemuel R Waitman; Cynthia S Gadd; Ioana Danciu; James P Smith; Julia B Lewis; Jonathan S Schildcrout; Josh F Peterson
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

Review 6.  Acute kidney injury in the elderly.

Authors:  Khaled Abdel-Kader; Paul M Palevsky
Journal:  Clin Geriatr Med       Date:  2009-08       Impact factor: 3.076

Review 7.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

9.  Hospital-acquired acute kidney injury in medical, surgical, and intensive care unit: A comparative study.

Authors:  T B Singh; S S Rathore; T A Choudhury; V K Shukla; D K Singh; J Prakash
Journal:  Indian J Nephrol       Date:  2013-01

10.  Development of a MALDI MS-based platform for early detection of acute kidney injury.

Authors:  Emma Carrick; Jill Vanmassenhove; Griet Glorieux; Jochen Metzger; Mohammed Dakna; Martin Pejchinovski; Vera Jankowski; Bahareh Mansoorian; Holger Husi; William Mullen; Harald Mischak; Raymond Vanholder; Wim Van Biesen
Journal:  Proteomics Clin Appl       Date:  2016-05-17       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.